New Enterprise Associates 17, L.P. - Insider Trading & Ownership

Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Summary
The estimated value of insider holdings of New Enterprise Associates 17, L.P. is at least $246M dollars as of October 6, 2025. New Enterprise Associates 17, L.P. is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. New Enterprise Associates 17, L.P. is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. New Enterprise Associates 17, L.P. is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.6M.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of New Enterprise Associates 17, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
KRRO Korro Bio, Inc. 10%+ Owner $61.1M Apr 22, 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38.6M Sep 16, 2024
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$1.89K -100% Oct 2, 2025

Insider Transactions Reported by New Enterprise Associates 17, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.